JP2002534507A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534507A5
JP2002534507A5 JP2000593587A JP2000593587A JP2002534507A5 JP 2002534507 A5 JP2002534507 A5 JP 2002534507A5 JP 2000593587 A JP2000593587 A JP 2000593587A JP 2000593587 A JP2000593587 A JP 2000593587A JP 2002534507 A5 JP2002534507 A5 JP 2002534507A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkoxy
alkyl
compound
oxides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000593587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002534507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/000152 external-priority patent/WO2000042019A1/en
Publication of JP2002534507A publication Critical patent/JP2002534507A/ja
Publication of JP2002534507A5 publication Critical patent/JP2002534507A5/ja
Withdrawn legal-status Critical Current

Links

JP2000593587A 1999-01-15 2000-01-12 新規6−アリールフェナントリジン Withdrawn JP2002534507A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100705.5 1999-01-15
EP99100705 1999-01-15
PCT/EP2000/000152 WO2000042019A1 (en) 1999-01-15 2000-01-12 6-arylphenanthridines with pde-iv inhibiting activity

Publications (2)

Publication Number Publication Date
JP2002534507A JP2002534507A (ja) 2002-10-15
JP2002534507A5 true JP2002534507A5 (cg-RX-API-DMAC7.html) 2007-03-01

Family

ID=8237353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593587A Withdrawn JP2002534507A (ja) 1999-01-15 2000-01-12 新規6−アリールフェナントリジン

Country Status (13)

Country Link
US (1) US6479505B1 (cg-RX-API-DMAC7.html)
EP (1) EP1147088B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002534507A (cg-RX-API-DMAC7.html)
AT (1) ATE315029T1 (cg-RX-API-DMAC7.html)
AU (1) AU2289400A (cg-RX-API-DMAC7.html)
CA (1) CA2359416A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105427T1 (cg-RX-API-DMAC7.html)
DE (1) DE60025327T2 (cg-RX-API-DMAC7.html)
DK (1) DK1147088T3 (cg-RX-API-DMAC7.html)
ES (1) ES2255483T3 (cg-RX-API-DMAC7.html)
PT (1) PT1147088E (cg-RX-API-DMAC7.html)
SI (1) SI1147088T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000042019A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05105B1 (et) * 1999-01-15 2008-12-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
SI1303506T1 (en) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarylphenanthridines
US6903109B2 (en) 2001-04-18 2005-06-07 Ortho-Muniel Pharmaceutical, Inc. Arylindenopyridines and related therapeutic and prophylactic methods
WO2002085894A1 (en) * 2001-04-18 2002-10-31 Ortho-Mcneil Pharmaceutical, Inc. Arylindenopyridines with pde inhibiting activity
US6958328B2 (en) 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
US20040127510A1 (en) 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
CA2495597A1 (en) * 2002-08-17 2004-03-04 Altana Pharma Ag Novel phenanthridines
CA2496459C (en) 2002-08-29 2013-06-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
EP1736471B1 (en) 2004-01-23 2014-01-08 Mitsui Chemicals Agro, Inc. 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
EP1720835B1 (en) 2004-02-18 2012-12-12 Nycomed GmbH Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
EP1856092A1 (en) * 2005-03-02 2007-11-21 Nycomed GmbH 6-heteroaryl-1,2,3,4,4a,10b-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
JP5164567B2 (ja) * 2005-05-17 2013-03-21 大鵬薬品工業株式会社 慢性副鼻腔炎の重症度および再発性の検査方法
NO340563B1 (no) * 2016-09-05 2017-05-15 Takeda Gmbh Nye salter av 6-heterocyklylsubstituerte heksahydrofenantridinderivater

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE03523B1 (et) 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
CA2250569C (en) * 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
PT1000035E (pt) 1997-07-25 2003-04-30 Altana Pharma Ag 6-fenilfenantridinas substituidas
AU753615B2 (en) 1997-07-25 2002-10-24 Altana Pharma Ag Novel tetrazole derivatives

Similar Documents

Publication Publication Date Title
RU2220144C2 (ru) Новые тетрациклические аналоги камптотецинов, способы их получения, промежуточные соединения и фармацевтическая композиция на их основе
JP2619904B2 (ja) 安定化された組成物
RU2000116011A (ru) Пероральная фармацевтическая лекарственная форма с продолжительным высвобождением
JP2010529147A5 (cg-RX-API-DMAC7.html)
CA2553269A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
JP2003500442A5 (cg-RX-API-DMAC7.html)
CA2494613A1 (en) Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
CA2430692A1 (en) Geldanamycin derivative and use of same to treat cancer
JP2003502278A5 (cg-RX-API-DMAC7.html)
NO331021B1 (no) Medikament for behandling av kreft omfattende kinolonderivater i kombinasjon med 5-FU eller CPT-11 samt anvendelse av derivatene
JP2006508913A5 (cg-RX-API-DMAC7.html)
CA2456817A1 (en) Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
JP2004501930A5 (cg-RX-API-DMAC7.html)
BR0013792A (pt) Derivados de amino-triazolopiridina
JP2006505505A5 (cg-RX-API-DMAC7.html)
NO20003723L (no) Triazol- og imidazolderivater
PE20030746A1 (es) DERIVADOS DE PIRIDO [2,1-a] ISOQUINOLINA
EP1566379A4 (en) CHINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES AS INHIBITORS OF FLT3 AUTOPHOSPHORYLATION AND THE MEDICAL COMPOSITIONS CONTAINING THEREOF
JP2001526211A5 (cg-RX-API-DMAC7.html)
WO2002055079A3 (en) Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
JP2004521105A5 (cg-RX-API-DMAC7.html)
HUP0001110A2 (hu) 3-Piridil-enantiomerek és analgetikumkénti alkalmazásuk
DK0923548T3 (da) 4-Aminoethoxyindoler som dopamin-D2-agonister og som 5HT 1A-ligander
NO20005385D0 (no) Orale legemiddelpreparater med reproduserbar virkestoffrigivning av gatifloxacin eller dens farmasøytisk anvendelige salter eller hydrater
HUP0103893A2 (hu) Heterociklusos csoporttal szubsztituált propanolaminszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk